IGM Biosciences Inc
NASDAQ:IGMS
Income Statement
Earnings Waterfall
IGM Biosciences Inc
Income Statement
IGM Biosciences Inc
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+89%
|
1
+53%
|
2
+49%
|
2
+5%
|
2
+11%
|
2
+15%
|
2
-1%
|
3
+38%
|
3
+0%
|
3
-8%
|
3
+0%
|
145
+5 310%
|
|
| Operating Income | ||||||||||||||||||||||||||
| Operating Expenses |
(33)
|
(38)
|
(45)
|
(56)
|
(65)
|
(74)
|
(83)
|
(96)
|
(116)
|
(139)
|
(165)
|
(186)
|
(206)
|
(223)
|
(229)
|
(241)
|
(250)
|
(256)
|
(266)
|
(256)
|
(240)
|
(224)
|
(197)
|
(174)
|
(134)
|
|
| Selling, General & Administrative |
(6)
|
(7)
|
(9)
|
(12)
|
(14)
|
(16)
|
(18)
|
(22)
|
(27)
|
(32)
|
(38)
|
(43)
|
(47)
|
(50)
|
(50)
|
(50)
|
(50)
|
(50)
|
(50)
|
(48)
|
(46)
|
(43)
|
(42)
|
(42)
|
(39)
|
|
| Research & Development |
(27)
|
(30)
|
(35)
|
(44)
|
(51)
|
(58)
|
(65)
|
(74)
|
(89)
|
(107)
|
(127)
|
(142)
|
(159)
|
(173)
|
(179)
|
(191)
|
(200)
|
(206)
|
(216)
|
(208)
|
(195)
|
(181)
|
(155)
|
(132)
|
(95)
|
|
| Operating Income |
(33)
N/A
|
(38)
-12%
|
(45)
-18%
|
(56)
-25%
|
(65)
-16%
|
(74)
-15%
|
(83)
-12%
|
(96)
-16%
|
(116)
-20%
|
(139)
-20%
|
(165)
-19%
|
(186)
-12%
|
(206)
-11%
|
(222)
-8%
|
(228)
-3%
|
(239)
-5%
|
(248)
-4%
|
(255)
-3%
|
(263)
-3%
|
(254)
+3%
|
(237)
+7%
|
(220)
+7%
|
(195)
+11%
|
(171)
+12%
|
10
N/A
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
7
|
10
|
14
|
17
|
18
|
18
|
17
|
15
|
13
|
11
|
8
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(14)
|
(14)
|
(38)
|
(72)
|
|
| Total Other Income |
(0)
|
0
|
1
|
2
|
3
|
3
|
2
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
(0)
|
1
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(34)
N/A
|
(37)
-11%
|
(43)
-15%
|
(53)
-24%
|
(61)
-15%
|
(72)
-16%
|
(81)
-14%
|
(95)
-17%
|
(115)
-21%
|
(139)
-21%
|
(165)
-19%
|
(185)
-12%
|
(205)
-11%
|
(219)
-7%
|
(221)
-1%
|
(228)
-3%
|
(234)
-2%
|
(238)
-2%
|
(246)
-3%
|
(236)
+4%
|
(220)
+7%
|
(219)
+0%
|
(196)
+11%
|
(199)
-2%
|
(53)
+73%
|
|
| Net Income | ||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(34)
|
(37)
|
(43)
|
(53)
|
(61)
|
(72)
|
(81)
|
(95)
|
(115)
|
(139)
|
(165)
|
(185)
|
(205)
|
(219)
|
(221)
|
(229)
|
(234)
|
(238)
|
(246)
|
(237)
|
(221)
|
(220)
|
(196)
|
(199)
|
(53)
|
|
| Net Income (Common) |
(34)
N/A
|
(37)
-11%
|
(43)
-15%
|
(53)
-24%
|
(61)
-15%
|
(72)
-16%
|
(81)
-14%
|
(95)
-17%
|
(115)
-21%
|
(139)
-21%
|
(165)
-19%
|
(185)
-12%
|
(205)
-11%
|
(219)
-7%
|
(221)
-1%
|
(229)
-3%
|
(234)
-3%
|
(238)
-2%
|
(246)
-3%
|
(237)
+4%
|
(221)
+7%
|
(220)
+0%
|
(196)
+11%
|
(199)
-2%
|
(53)
+73%
|
|
| EPS (Diluted) |
-1.17
N/A
|
-1.22
-4%
|
-1.41
-16%
|
-1.74
-23%
|
-2.02
-16%
|
-2.35
-16%
|
-2.65
-13%
|
-2.86
-8%
|
-3.45
-21%
|
-4.16
-21%
|
-4.93
-19%
|
-5.46
-11%
|
-4.67
+14%
|
-4.97
-6%
|
-5.32
-7%
|
-5.12
+4%
|
-5.19
-1%
|
-3.99
+23%
|
-4.73
-19%
|
-3.94
+17%
|
-3.67
+7%
|
-3.59
+2%
|
-3.21
+11%
|
-3.26
-2%
|
-0.85
+74%
|
|